Cempra (CEMP) on Watch as FDA Briefing Docs Published
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil rises as renewed US-Iran strikes stoke supply fears
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
Cempra (CEMP) Shares Halted Ahead of FDA AdCom on Solithromycin as CABP Treatment
November 4, 2016 7:06 AM EDTCempra, Inc. (Nasdaq: CEMP) announced that NASDAQ has halted trading of the company's common... More
Stifel Downgrades Cempra, Inc. (CEMP) to Hold
November 3, 2016 7:23 AM EDTStifel downgraded Cempra, Inc. (NASDAQ: CEMP) from Buy to Hold with a price target of $8.00.
For an analyst ratings summary and ratings history on Cempra, Inc. click here. For more ratings news on Cempra, Inc. click here.
Shares of Cempra, Inc. closed at $7.30 yesterday.
... MoreRaymond James Downgrades Cempra, Inc. (CEMP) to Market Perform
November 2, 2016 12:49 PM EDTRaymond James earlier downgraded Cempra, Inc. (NASDAQ: CEMP) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Cempra, Inc. click here. For more ratings news on Cempra, Inc. click here.
Shares of Cempra, Inc. closed at $18.65 yesterday.
... More